{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:05:04Z","timestamp":1778645104882,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Instituitional funds"},{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["R01 AT009152"],"award-info":[{"award-number":["R01 AT009152"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P30 ES005022"],"award-info":[{"award-number":["P30 ES005022"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Indole-3-carbinol (I3C) is  shown to possess multiple pharmacological activities such as anti-inflammatory, antimicrobial, antioxidant, antiviral, and anti-cancer activities. It is widely accepted as modulator of multiple signaling pathways particularly those related to cell cycle, cell growth and division, angiogenesis, apoptosis and immunity.\u00a0We explored the metabolic reprogramming based on\u00a0treatment with\u00a0I3C in mice prostate tissue.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this study we utilized Pten knockout (KO)-induced prostate tumorigenesis mouse model to examine mechanism of action of I3C via metabolic rewiring. Phosphatase and tensin homolog deleted on chromosome 10 (Pten), a tumor suppressor gene is frequently found to be mutated or deleted in prostate cancer. Untargeted metabolomics was performed using liquid-chromatography mass-spectrometry (LC\u2013MS) based platform to investigate Pten-dependent and Pten-independent metabolic targets of I3C.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The most impacted pathways by I3C included pyrimidine metabolism, arginine and proline metabolism, porphyrin metabolism, citrate cycle and lipoic acid metabolism.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>These pathways taken together help in understanding the overall health beneficial effects of I3C.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11095-025-03820-8","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T21:14:28Z","timestamp":1738703668000},"page":"237-247","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dietary phytochemical indole-3-carbinol regulates metabolic reprogramming in mouse prostate tissue"],"prefix":"10.1007","volume":"42","author":[{"given":"Rebecca Mary","family":"Peter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Shahid","family":"Sarwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lujing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pochung","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyang","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9273-4217","authenticated-orcid":false,"given":"Ah-Ng","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"issue":"3","key":"3820_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/annonc\/mdl498","volume":"18","author":"J Ferlay","year":"2007","unstructured":"Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18(3):581\u201392. https:\/\/doi.org\/10.1093\/annonc\/mdl498. (Epub 2007\/02\/09 PubMed PMID: 17287242).","journal-title":"Ann Oncol"},{"issue":"12","key":"3820_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41389-017-0007-5","volume":"6","author":"DA Dart","year":"2017","unstructured":"Dart DA, Uysal-Onganer P, Jiang WG. Prostate-specific PTen deletion in mice activates inflammatory microRNA expression pathways in the epithelium early in hyperplasia development. Oncogenesis. 2017;6(12):400. https:\/\/doi.org\/10.1038\/s41389-017-0007-5. (Epub 2017\/12\/30 PubMed PMID: 29284790; PMCID: PMC5865543).","journal-title":"Oncogenesis"},{"issue":"3","key":"3820_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/s1535-6108(03)00215-0","volume":"4","author":"S Wang","year":"2003","unstructured":"Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J, Thomas GV, Li G, Roy-Burman P, Nelson PS, Liu X, Wu H. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell. 2003;4(3):209\u201321. https:\/\/doi.org\/10.1016\/s1535-6108(03)00215-0. (Epub 2003\/10\/03 PubMed PMID: 14522255).","journal-title":"Cancer Cell"},{"issue":"2","key":"3820_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0002-9440(10)64200-9","volume":"161","author":"XP Zhou","year":"2002","unstructured":"Zhou XP, Loukola A, Salovaara R, Nystrom-Lahti M, Peltomaki P, de la Chapelle A, Aaltonen LA, Eng C. PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers. Am J Pathol. 2002;161(2):439\u201347. https:\/\/doi.org\/10.1016\/S0002-9440(10)64200-9. (Epub 2002\/08\/07 PubMed PMID: 12163369; PMCID: PMC1850747).","journal-title":"Am J Pathol"},{"issue":"2","key":"3820_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1677\/erc.0.0070115","volume":"7","author":"PL Dahia","year":"2000","unstructured":"Dahia PL. PTEN, a unique tumor suppressor gene. Endocr Relat Cancer. 2000;7(2):115\u201329. https:\/\/doi.org\/10.1677\/erc.0.0070115. (Epub 2000\/07\/21 Epub 2000\/07\/21).","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"3820_CR6","first-page":"204","volume":"58","author":"H Suzuki","year":"1998","unstructured":"Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, Isaacs WB, Bova GS. Interfocal heterogeneity of PTEN\/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res. 1998;58(2):204\u20139 (Epub 1998\/01\/27 PubMed PMID: 9443392).","journal-title":"Cancer Res"},{"key":"3820_CR7","doi-asserted-by":"publisher","unstructured":"Zadra G, Loda M. Metabolic Vulnerabilities of Prostate Cancer: Diagnostic and Therapeutic Opportunities. Cold Spring Harb Perspect Med. 2018;8(10). Epub 2017\/12\/13. https:\/\/doi.org\/10.1101\/cshperspect.a030569. PubMed PMID: 29229664; PMCID: PMC6169980.","DOI":"10.1101\/cshperspect.a030569"},{"key":"3820_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-3-319-41334-1_6","volume":"928","author":"B Licznerska","year":"2016","unstructured":"Licznerska B, Baer-Dubowska W. Indole-3-Carbinol and Its Role in Chronic Diseases. Adv Exp Med Biol. 2016;928:131\u201354. https:\/\/doi.org\/10.1007\/978-3-319-41334-1_6. (Epub 2016\/09\/28 PubMed PMID: 27671815).","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"3820_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.canlet.2008.01.033","volume":"262","author":"JR Weng","year":"2008","unstructured":"Weng JR, Tsai CH, Kulp SK, Chen CS. Indole-3-carbinol as a chemopreventive and anti-cancer agent. Cancer Lett. 2008;262(2):153\u201363. https:\/\/doi.org\/10.1016\/j.canlet.2008.01.033. (Epub 2008\/03\/04 PubMed PMID: 18314259; PMCID: PMC2814317).","journal-title":"Cancer Lett"},{"issue":"5","key":"3820_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/bdd.759","volume":"32","author":"CL Saw","year":"2011","unstructured":"Saw CL, Cintron M, Wu TY, Guo Y, Huang Y, Jeong WS, Kong AN. Pharmacodynamics of dietary phytochemical indoles I3C and DIM: Induction of Nrf2-mediated phase II drug metabolizing and antioxidant genes and synergism with isothiocyanates. Biopharm Drug Dispos. 2011;32(5):289\u2013300. https:\/\/doi.org\/10.1002\/bdd.759. (Epub 2011\/06\/10 PubMed PMID: 21656528; PMCID: PMC3465716).","journal-title":"Biopharm Drug Dispos"},{"issue":"2","key":"3820_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.5483\/bmbrep.2005.38.2.167","volume":"38","author":"WS Jeong","year":"2005","unstructured":"Jeong WS, Keum YS, Chen C, Jain MR, Shen G, Kim JH, Li W, Kong AN. Differential expression and stability of endogenous nuclear factor E2-related factor 2 (Nrf2) by natural chemopreventive compounds in HepG2 human hepatoma cells. J Biochem Mol Biol. 2005;38(2):167\u201376. https:\/\/doi.org\/10.5483\/bmbrep.2005.38.2.167. (Epub 2005\/04\/14 PubMed PMID: 15826493).","journal-title":"J Biochem Mol Biol"},{"issue":"7","key":"3820_CR12","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1023\/a:1016006707613","volume":"13","author":"P Fei","year":"1996","unstructured":"Fei P, Matwyshyn GA, Rushmore TH, Kong AN. Transcription regulation of rat glutathione S-transferase Ya subunit gene expression by chemopreventive agents. Pharm Res. 1996;13(7):1043\u20138. https:\/\/doi.org\/10.1023\/a:1016006707613. (Epub 1996\/07\/01 PubMed PMID: 8842042).","journal-title":"Pharm Res"},{"issue":"7","key":"3820_CR13","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1023\/a:1016291305564","volume":"12","author":"BK Wong","year":"1995","unstructured":"Wong BK, Fei P, Kong AN. Differential induction of UDP-glucuronosyltransferase activity and gene expression in rat liver. Pharm Res. 1995;12(7):1105\u20138. https:\/\/doi.org\/10.1023\/a:1016291305564. (Epub 1995\/07\/01 Epub 1995\/07\/01).","journal-title":"Pharm Res"},{"issue":"10","key":"3820_CR14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/mc.20841","volume":"51","author":"TY Wu","year":"2012","unstructured":"Wu TY, Saw CL, Khor TO, Pung D, Boyanapalli SS, Kong AN. In vivo pharmacodynamics of indole-3-carbinol in the inhibition of prostate cancer in transgenic adenocarcinoma of mouse prostate (TRAMP) mice: involvement of Nrf2 and cell cycle\/apoptosis signaling pathways. Mol Carcinog. 2012;51(10):761\u201370. https:\/\/doi.org\/10.1002\/mc.20841. (Epub 2011\/08\/13 Epub 2011\/08\/13).","journal-title":"Mol Carcinog"},{"issue":"3","key":"3820_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s40495-015-0017-y","volume":"1","author":"F Fuentes","year":"2015","unstructured":"Fuentes F, Paredes-Gonzalez X, Kong AN. Dietary Glucosinolates Sulforaphane, Phenethyl Isothiocyanate, Indole-3-Carbinol\/3,3\u2019-Diindolylmethane: Anti-Oxidative Stress\/Inflammation, Nrf2, Epigenetics\/Epigenomics and In Vivo Cancer Chemopreventive Efficacy. Curr Pharmacol Rep. 2015;1(3):179\u201396. https:\/\/doi.org\/10.1007\/s40495-015-0017-y. (Epub 2015\/10\/13 PubMed PMID: 26457242; PMCID: PMC4596548).","journal-title":"Curr Pharmacol Rep"},{"issue":"1","key":"3820_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jss.2016.04.021","volume":"204","author":"BW Megna","year":"2016","unstructured":"Megna BW, Carney PR, Nukaya M, Geiger P, Kennedy GD. Indole-3-carbinol induces tumor cell death: function follows form. J Surg Res. 2016;204(1):47\u201354. https:\/\/doi.org\/10.1016\/j.jss.2016.04.021. (Epub 2016\/07\/28 PubMed PMID: 27451867; PMCID: PMC4964970).","journal-title":"J Surg Res"},{"issue":"12 Suppl","key":"3820_CR17","doi-asserted-by":"publisher","first-page":"3493S","DOI":"10.1093\/jn\/134.12.3493S","volume":"134","author":"FH Sarkar","year":"2004","unstructured":"Sarkar FH, Li Y. Indole-3-carbinol and prostate cancer. J Nutr. 2004;134(12 Suppl):3493S-8S. https:\/\/doi.org\/10.1093\/jn\/134.12.3493S. (Epub 2004\/12\/01 PubMed PMID: 15570059).","journal-title":"J Nutr."},{"issue":"11","key":"3820_CR18","doi-asserted-by":"publisher","first-page":"e22626","DOI":"10.1096\/fj.202201195R","volume":"36","author":"L Wang","year":"2022","unstructured":"Wang L, Wang C, Sarwar MS, Chou P, Wang Y, Su X, Kong AT. PTEN-knockout regulates metabolic rewiring and epigenetic reprogramming in prostate cancer and chemoprevention by triterpenoid ursolic acid. FASEB J. 2022;36(11):e22626. https:\/\/doi.org\/10.1096\/fj.202201195R. (Epub 2022\/10\/29 Epub 2022\/10\/29).","journal-title":"FASEB J"},{"issue":"1","key":"3820_CR19","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1096\/fj.201901205RR","volume":"34","author":"C Wang","year":"2020","unstructured":"Wang C, Feng Y, Zhang C, Cheng D, Wu R, Yang Y, Sargsyan D, Kumar D, Kong AN. PTEN deletion drives aberrations of DNA methylome and transcriptome in different stages of prostate cancer. FASEB J. 2020;34(1):1304\u201318. https:\/\/doi.org\/10.1096\/fj.201901205RR. (Epub 2020\/01\/10 PubMed PMID: 31914691; PMCID: PMC6956734.).","journal-title":"FASEB J"},{"key":"3820_CR20","doi-asserted-by":"publisher","unstructured":"Loh ZN, Wang ME, Wan C, Asara JM, Ji Z, Chen M. Nuclear PTEN Regulates Thymidylate Biosynthesis in Human Prostate Cancer Cell Lines. Metabolites. 2023;13(8). Epub 2023\/08\/25. https:\/\/doi.org\/10.3390\/metabo13080939. PubMed PMID: 37623882; PMCID: PMC10456368.","DOI":"10.3390\/metabo13080939"},{"issue":"1","key":"3820_CR21","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1186\/s12885-023-11707-3","volume":"23","author":"X Dai","year":"2023","unstructured":"Dai X, Shi X, Luo M, Li P, Gao Y. Integrative analysis of transcriptomic and metabolomic profiles reveals enhanced arginine metabolism in androgen-independent prostate cancer cells. BMC Cancer. 2023;23(1):1241. https:\/\/doi.org\/10.1186\/s12885-023-11707-3. (Epub 2023\/12\/17 PubMed PMID: 38104097; PMCID: PMC10724921).","journal-title":"BMC Cancer"},{"key":"3820_CR22","doi-asserted-by":"publisher","unstructured":"Matos A, Carvalho M, Bicho M, Ribeiro R. Arginine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate Cancer Progression. Nutrients. 2021;13(12). Epub 2021\/12\/29. https:\/\/doi.org\/10.3390\/nu13124503. PubMed PMID: 34960055; PMCID: PMC8704013.","DOI":"10.3390\/nu13124503"},{"issue":"11","key":"3820_CR23","doi-asserted-by":"publisher","first-page":"109252","DOI":"10.1016\/j.celrep.2021.109252","volume":"35","author":"V Fiorito","year":"2021","unstructured":"Fiorito V, Allocco AL, Petrillo S, Gazzano E, Torretta S, Marchi S, Destefanis F, Pacelli C, Audrito V, Provero P, Medico E, Chiabrando D, Porporato PE, Cancelliere C, Bardelli A, Trusolino L, Capitanio N, Deaglio S, Altruda F, Pinton P, Cardaci S, Riganti C, Tolosano E. The heme synthesis-export system regulates the tricarboxylic acid cycle flux and oxidative phosphorylation. Cell Rep. 2021;35(11):109252. https:\/\/doi.org\/10.1016\/j.celrep.2021.109252. (Epub 2021\/06\/17 Epub 2021\/06\/17).","journal-title":"Cell Rep"},{"key":"3820_CR24","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3389\/fgene.2020.00510","volume":"11","author":"JE Cronan","year":"2020","unstructured":"Cronan JE. Progress in the Enzymology of the Mitochondrial Diseases of Lipoic Acid Requiring Enzymes. Front Genet. 2020;11:510. https:\/\/doi.org\/10.3389\/fgene.2020.00510. (Epub 2020\/06\/09 PubMed PMID: 32508887; PMCID: PMC7253636).","journal-title":"Front Genet"},{"issue":"4","key":"3820_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.tem.2012.11.002","volume":"24","author":"A Ortega-Molina","year":"2013","unstructured":"Ortega-Molina A, Serrano M. PTEN in cancer, metabolism, and aging. Trends Endocrinol Metab. 2013;24(4):184\u20139. https:\/\/doi.org\/10.1016\/j.tem.2012.11.002. (Epub 2012\/12\/19 PubMed PMID: 23245767; PMCID: PMC3836169).","journal-title":"Trends Endocrinol Metab."},{"key":"3820_CR26","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fendo.2018.00338","volume":"9","author":"CY Chen","year":"2018","unstructured":"Chen CY, Chen J, He L, Stiles BL. PTEN: Tumor Suppressor and Metabolic Regulator. Front Endocrinol (Lausanne). 2018;9:338. https:\/\/doi.org\/10.3389\/fendo.2018.00338. (Epub 2018\/07\/25 PubMed PMID: 30038596; PMCID: PMC6046409).","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"3","key":"3820_CR27","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.3892\/ol.2019.9932","volume":"17","author":"X Zhou","year":"2019","unstructured":"Zhou X, Yang X, Sun X, Xu X, Li X, Guo Y, Wang J, Li X, Yao L, Wang H, Shen L. Effect of PTEN loss on metabolic reprogramming in prostate cancer cells. Oncol Lett. 2019;17(3):2856\u201366. https:\/\/doi.org\/10.3892\/ol.2019.9932. (Epub 2019\/03\/12 PubMed PMID: 30854061; PMCID: PMC6386093).","journal-title":"Oncol Lett"},{"key":"3820_CR28","doi-asserted-by":"publisher","first-page":"684961","DOI":"10.3389\/fonc.2021.684961","volume":"11","author":"W Wang","year":"2021","unstructured":"Wang W, Cui J, Ma H, Lu W, Huang J. Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine. Front Oncol. 2021;11:684961. https:\/\/doi.org\/10.3389\/fonc.2021.684961. (Epub 2021\/06\/15 PubMed PMID: 34123854; PMCID: PMC8194085).","journal-title":"Front Oncol"},{"issue":"6125","key":"3820_CR29","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.1228771","volume":"339","author":"AM Robitaille","year":"2013","unstructured":"Robitaille AM, Christen S, Shimobayashi M, Cornu M, Fava LL, Moes S, Prescianotto-Baschong C, Sauer U, Jenoe P, Hall MN. Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis. Science. 2013;339(6125):1320\u20133. https:\/\/doi.org\/10.1126\/science.1228771. (Epub 2013\/02\/23 PubMed PMID: 23429704).","journal-title":"Science."},{"issue":"6125","key":"3820_CR30","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1126\/science.1228792","volume":"339","author":"I Ben-Sahra","year":"2013","unstructured":"Ben-Sahra I, Howell JJ, Asara JM, Manning BD. Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science. 2013;339(6125):1323\u20138. https:\/\/doi.org\/10.1126\/science.1228792. (Epub 2013\/02\/23 PubMed PMID: 23429703; PMCID: PMC3753690).","journal-title":"Science."},{"issue":"9","key":"3820_CR31","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.molmed.2005.07.003","volume":"11","author":"M Loffler","year":"2005","unstructured":"Loffler M, Fairbanks LD, Zameitat E, Marinaki AM, Simmonds HA. Pyrimidine pathways in health and disease. Trends Mol Med. 2005;11(9):430\u20137. https:\/\/doi.org\/10.1016\/j.molmed.2005.07.003. (Epub 2005\/08\/16 Epub 2005\/08\/16).","journal-title":"Trends Mol Med"},{"issue":"4","key":"3820_CR32","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1158\/2159-8290.CD-16-0612","volume":"7","author":"D Mathur","year":"2017","unstructured":"Mathur D, Stratikopoulos E, Ozturk S, Steinbach N, Pegno S, Schoenfeld S, Yong R, Murty VV, Asara JM, Cantley LC, Parsons R. PTEN Regulates Glutamine Flux to Pyrimidine Synthesis and Sensitivity to Dihydroorotate Dehydrogenase Inhibition. Cancer Discov. 2017;7(4):380\u201390. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-0612. (PubMed PMID PMCID: PMC5562025).","journal-title":"Cancer Discov"},{"key":"3820_CR33","doi-asserted-by":"publisher","unstructured":"Lumeau A, Bery N, Frances A, Gayral M, Labrousse G, Ribeyre C, Lopez C, Nevot A, El Kaoutari A, Hanoun N, Sarot E, Perrier M, Pont F, Cerapio JP, Fournie JJ, Lopez F, Madrid-Mencia M, Pancaldi V, Pillaire MJ, Bergoglio V, Torrisani J, Dusetti N, Hoffmann JS, Buscail L, Lutzmann M, Cordelier P. Cytidine deaminase resolves replicative stress and protects pancreatic cancer from DNA-targeting drugs. Cancer Res. 2024. Epub 2024\/01\/31. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-3219. PubMed PMID: 38294491.","DOI":"10.1158\/0008-5472.CAN-22-3219"},{"key":"3820_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41420-020-00341-8","volume":"6","author":"L Burke","year":"2020","unstructured":"Burke L, Guterman I, Palacios Gallego R, Britton RG, Burschowsky D, Tufarelli C, Rufini A. The Janus-like role of proline metabolism in cancer. Cell Death Discov. 2020;6:104. https:\/\/doi.org\/10.1038\/s41420-020-00341-8. (Epub 2020\/10\/22 PubMed PMID: 33083024; PMCID: PMC7560826).","journal-title":"Cell Death Discov"},{"issue":"10","key":"3820_CR35","doi-asserted-by":"publisher","first-page":"25865","DOI":"10.3390\/ijms161025865","volume":"16","author":"X Yang","year":"2015","unstructured":"Yang X, Palasuberniam P, Kraus D, Chen B. Aminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for Enhancement. Int J Mol Sci. 2015;16(10):25865\u201380. https:\/\/doi.org\/10.3390\/ijms161025865. (Epub 2015\/10\/31 PubMed PMID: 26516850; PMCID: PMC4632830).","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3820_CR36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/sj.pcan.4500712","volume":"7","author":"LC Costello","year":"2004","unstructured":"Costello LC, Feng P, Milon B, Tan M, Franklin RB. Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve. Prostate Cancer Prostatic Dis. 2004;7(2):111\u20137. https:\/\/doi.org\/10.1038\/sj.pcan.4500712. (PubMed PMID: 15175662; PMCID: PMC4464831).","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"12","key":"3820_CR37","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.4161\/cbt.12.12.18367","volume":"12","author":"LC Costello","year":"2011","unstructured":"Costello LC, Franklin RB, Zou J, Feng P, Bok R, Swanson MG, Kurhanewicz J. Human prostate cancer ZIP1\/zinc\/citrate genetic\/metabolic relationship in the TRAMP prostate cancer animal model. Cancer Biol Ther. 2011;12(12):1078\u201384 (Epub 2011\/12\/14 PubMed PMID: 22156800; PMCID: PMC3335941).","journal-title":"Cancer Biol Ther."},{"issue":"20","key":"3820_CR38","doi-asserted-by":"publisher","first-page":"7522","DOI":"10.1074\/jbc.TM117.000259","volume":"293","author":"A Solmonson","year":"2018","unstructured":"Solmonson A, DeBerardinis RJ. Lipoic acid metabolism and mitochondrial redox regulation. J Biol Chem. 2018;293(20):7522\u201330. https:\/\/doi.org\/10.1074\/jbc.TM117.000259. (Epub 2017\/12\/02 PubMed PMID: 29191830; PMCID: PMC5961061).","journal-title":"J Biol Chem."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03820-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-025-03820-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03820-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T08:54:08Z","timestamp":1741164848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-025-03820-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["3820"],"URL":"https:\/\/doi.org\/10.1007\/s11095-025-03820-8","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors do not declare competing financial interests or personal relationships that might influence the work reported in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}